A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients
Clinical trial NCT07052994 · WITHDRAWN
Trial details
- NCT number
- NCT07052994
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-21
- Primary completion
- 2026-05-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.